When.com Web Search

  1. Ads

    related to: tadalafil indications of use in children with anxiety reviews journal author

Search results

  1. Results From The WOW.Com Content Network
  2. Journal of Child and Adolescent Psychopharmacology

    en.wikipedia.org/wiki/Journal_of_child_and...

    The Journal of Child and Adolescent Psychopharmacology is a peer-reviewed medical journal covering psychopharmacology in children and adolescents. It was established in 1990 and is published ten times per year by Mary Ann Liebert. The editor-in-chief is Harold S. Koplewicz (Child Mind Institute).

  3. Cialis Side Effects: What to Expect (& How to Avoid Them) - AOL

    www.aol.com/cialis-side-effects-expect-avoid...

    Remember, tadalafil 5-milligram side effects tend to be less severe than those experienced with 10- or 20-milligram dosages. Your provider may recommend adjusting your Cialis dosage if you’re ...

  4. Tadalafil: Your Ultimate Guide to Dosages, Side Effects & More

    www.aol.com/tadalafil-ultimate-guide-dosages...

    For once-daily use, tadalafil is prescribed at a lower dosage of either 2.5mg or 5mg per day. ... In a 2017 scientific review, researchers found that L-citrulline supplementation may increase ...

  5. Is It Safe to Take Cialis Daily? - AOL

    www.aol.com/safe-cialis-daily-115900442.html

    Because Cialis works all the time, it can provide you with a helpful confidence boost to reduce anxiety before intercourse. This, in turn, can help get you in the mood. Reduced risk of side effects.

  6. Child Indicators Research - Wikipedia

    en.wikipedia.org/wiki/Child_Indicators_Research

    Child Indicators Research is a bimonthly peer-reviewed scientific journal covering research on well-being in children. It was established in 2008 and is published by Springer Science+Business Media on behalf of the International Society for Child Indicators, of which it is the official journal.

  7. Serotonin–norepinephrine reuptake inhibitor - Wikipedia

    en.wikipedia.org/wiki/Serotonin–norepinephrine...

    A literature review by Castagna, et. al from 2023 shows indications of efficacy treating pediatric generalized anxiety disorder. Currently, Duloxetine, an SNRI, is the only FDA-approved medication for pediatric GAD, despite the fact that SSRIs are typically first-line treatment.